Skip to main content
. 2019 Jun 20;25(11):1415–1421. doi: 10.1016/j.cmi.2019.06.012

Table 3.

Adverse outcomes

Variable Intervention group Control group Difference (95% CI) Odds ratio (95% CI)
Intention-to-treat analysis
No. of study participants 398 402
 ICU admission 4 (1.0) 6 (1.5) –0.5 (–2.0 to 1.1) 0.67 (0.19–2.39)
 Death during hospitalization 2 (0.5) 3 (0.8) –0.2 (–1.3 to 0.9) 0.67 (0.11–4.04)
 Readmission within 30 daysa 23/392 (5.9) 27/394 (6.9) –1.0 (–4.4 to 2.4) 0.85 (0.48–1.51)
 Death within 30 daysa 3/392 (0.8) 4/394 (1.0) –0.3 (–1.6 to 1.1) 0.75 (0.17–3.38)
Per-protocol analysis
No. of study participants 383 378
 ICU admission 4 (1.0) 5 (1.3) –0.3 (–1.8 to 1.3) 0.79 (0.21–2.96)
 Death during hospitalization 2 (0.5) 3 (0.8) –0.3 (– 1.4 to 0.9) 0.66 (0.11–3.95)
 Readmission within 30 daysa 22/377 (5.8) 26/370 (7.0) –1.2 (–4.7 to 2.3) 0.82 (0.46–1.47)
 Death within 30 daysa 3/377 (0.8) 4/370 (1.1) –0.3 (–1.7 to 1,1) 0.73 (0.16–3.30)

ICU, intensive care unit.

Data are presented as per cent for categorical variables. Difference between intervention and control group was compared using χ2 tests and logistic regression model was used to calculate unadjusted odds ratios.

a

The denominator is the number of study participants that were followed up at day 30.